{
    "xml": "<topic id=\"PHP3463\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/tigecycline\" basename=\"tigecycline\" title=\"TIGECYCLINE\">\n<title>TIGECYCLINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1069\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/tigecycline\">Tigecycline</xref>\n</p>\n<data name=\"vtmid\">418631002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_612355832\" title=\"Glycylcycline antibacterials\">Glycylcycline antibacterials</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP48672\" outputclass=\"drugAction\" rev=\"1.12\" parent=\"/drugs/tigecycline\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Tigecycline is a glycylcycline antibacterial structurally related to the tetracyclines. Tigecycline is active against Gram-positive and Gram-negative bacteria, including tetracycline-resistant organisms, and some anaerobes. It is also active against meticillin-resistant <ph outputclass=\"organism\">\n<i>Staphylococcus aureus</i>\n</ph> and vancomycin-resistant enterococci, but <ph outputclass=\"organism\">\n<i>Pseudomonas aeruginosa</i>\n</ph> and many strains of <ph outputclass=\"organism\">\n<i>Proteus spp</i>\n</ph> are resistant to tigecycline.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48657\" outputclass=\"indicationsAndDose\" rev=\"1.31\" parent=\"/drugs/tigecycline\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of complicated skin and soft-tissue infections and complicated abdominal infections caused by multiple-antibacterial resistant organisms when other antibacterials cannot be used</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 100&#8239;mg, then 50&#8239;mg every 12&#8239;hours for 5&#8211;14 days, not recommended for the treatment of foot infections in patients with diabetes.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48690\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/tigecycline\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Cholestasis</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48654\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/tigecycline\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (tigecycline).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48629\" outputclass=\"sideEffects\" rev=\"1.25\" parent=\"/drugs/tigecycline\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">bilirubinaemia</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hypoglycaemia</ph>; <ph outputclass=\"sideEffect\">injection-site reactions</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">prolonged activated partial thromboplastin time</ph>; <ph outputclass=\"sideEffect\">prolonged prothrombin time</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Cholestatic jaundice</ph>; <ph outputclass=\"sideEffect\">hypoproteinaemia</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Antibiotic-associated colitis</ph>; <ph outputclass=\"sideEffect\">hepatic failure</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p>Side-effects similar to those of the tetracyclines can potentially occur.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48714\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.13\" parent=\"/drugs/tigecycline\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityContraindications\">\n<sectiondiv>\n<p>Contra-indicated in patients hypersensitive to tetracyclines.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48649\" outputclass=\"pregnancy\" parent=\"/drugs/tigecycline\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Tetracyclines should <b>not</b> be given to pregnant women; effects on skeletal development have been documented in the first trimester in <i>animal</i> studies. Administration during the second or third trimester may cause discoloration of the child&#8217;s teeth, and maternal hepatotoxicity has been reported with large parenteral doses.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48700\" outputclass=\"breastFeeding\" parent=\"/drugs/tigecycline\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48663\" outputclass=\"hepaticImpairment\" parent=\"/drugs/tigecycline\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Initially 100&#8239;mg then 25&#8239;mg every 12 hours in severe hepatic impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48726\" outputclass=\"directionsForAdministration\" rev=\"1.13\" parent=\"/drugs/tigecycline\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For <i>intravenous infusion</i> (<i>Tygacil</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9%. Reconstitute each vial with 5.3&#8239;mL infusion fluid to produce a 10&#8239;mg/mL solution; dilute requisite dose in 100&#8239;mL infusion fluid; give over 30&#8211;60 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3463-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/tigecycline\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75849\" title=\"Powder for solution for infusion\" namespace=\"/drugs/tigecycline/powder-for-solution-for-infusion\">Powder for solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78289\" namespace=\"/treatment-summaries/mrsa\" title=\"MRSA\" count=\"1\" rel=\"backlink\">MRSA</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1069\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/tigecycline\" title=\"Tigecycline\" count=\"1\" rel=\"link\">Tigecycline</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75849\" namespace=\"/drugs/tigecycline/powder-for-solution-for-infusion\" title=\"Powder for solution for infusion\" count=\"1\" rel=\"link\">Powder for solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP3463",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/tigecycline",
    "basename": "tigecycline",
    "title": "TIGECYCLINE",
    "interactants": [
        {
            "id": "bnf_int_1069",
            "label": "Tigecycline"
        }
    ],
    "vtmid": "418631002",
    "drugClassification": [
        "Glycylcycline antibacterials"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Tigecycline is a glycylcycline antibacterial structurally related to the tetracyclines. Tigecycline is active against Gram-positive and Gram-negative bacteria, including tetracycline-resistant organisms, and some anaerobes. It is also active against meticillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, but Pseudomonas aeruginosa and many strains of Proteus spp are resistant to tigecycline.",
                "html": "<p>Tigecycline is a glycylcycline antibacterial structurally related to the tetracyclines. Tigecycline is active against Gram-positive and Gram-negative bacteria, including tetracycline-resistant organisms, and some anaerobes. It is also active against meticillin-resistant <ph outputclass=\"organism\">\n<i>Staphylococcus aureus</i>\n</ph> and vancomycin-resistant enterococci, but <ph outputclass=\"organism\">\n<i>Pseudomonas aeruginosa</i>\n</ph> and many strains of <ph outputclass=\"organism\">\n<i>Proteus spp</i>\n</ph> are resistant to tigecycline.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of complicated skin and soft-tissue infections and complicated abdominal infections caused by multiple-antibacterial resistant organisms when other antibacterials cannot be used",
                        "html": "Treatment of complicated skin and soft-tissue infections and complicated abdominal infections caused by multiple-antibacterial resistant organisms when other antibacterials cannot be used"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 100 mg, then 50 mg every 12 hours for 5&#8211;14 days, not recommended for the treatment of foot infections in patients with diabetes.",
                        "html": "<p>Initially 100&#8239;mg, then 50&#8239;mg every 12&#8239;hours for 5&#8211;14 days, not recommended for the treatment of foot infections in patients with diabetes.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Cholestasis",
                "html": "Cholestasis"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (tigecycline).",
                "html": "<p>Appendix 1 (tigecycline).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "bilirubinaemia",
                        "html": "bilirubinaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypoglycaemia",
                        "html": "hypoglycaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "injection-site reactions",
                        "html": "injection-site reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "prolonged activated partial thromboplastin time",
                        "html": "prolonged activated partial thromboplastin time",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "prolonged prothrombin time",
                        "html": "prolonged prothrombin time",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Cholestatic jaundice",
                        "html": "Cholestatic jaundice",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypoproteinaemia",
                        "html": "hypoproteinaemia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Antibiotic-associated colitis",
                        "html": "Antibiotic-associated colitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hepatic failure",
                        "html": "hepatic failure",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "textContent": "Side-effects similar to those of the tetracyclines can potentially occur.",
                "html": "<p>Side-effects similar to those of the tetracyclines can potentially occur.</p>"
            }
        ]
    },
    "allergyAndCrossSensitivity": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Contra-indicated in patients hypersensitive to tetracyclines.",
                "html": "<p>Contra-indicated in patients hypersensitive to tetracyclines.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Tetracyclines should not be given to pregnant women; effects on skeletal development have been documented in the first trimester in animal studies. Administration during the second or third trimester may cause discoloration of the child&#8217;s teeth, and maternal hepatotoxicity has been reported with large parenteral doses.",
                "html": "<p>Tetracyclines should <b>not</b> be given to pregnant women; effects on skeletal development have been documented in the first trimester in <i>animal</i> studies. Administration during the second or third trimester may cause discoloration of the child&#8217;s teeth, and maternal hepatotoxicity has been reported with large parenteral doses.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution&#8212;present in milk in animal studies.",
                "html": "<p>Manufacturer advises caution&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Initially 100 mg then 25 mg every 12 hours in severe hepatic impairment.",
                "html": "<p>Initially 100&#8239;mg then 25&#8239;mg every 12 hours in severe hepatic impairment.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "For intravenous infusion (Tygacil ), give intermittently in Glucose 5% or Sodium Chloride 0.9%. Reconstitute each vial with 5.3 mL infusion fluid to produce a 10 mg/mL solution; dilute requisite dose in 100 mL infusion fluid; give over 30&#8211;60 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Tygacil</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9%. Reconstitute each vial with 5.3&#8239;mL infusion fluid to produce a 10&#8239;mg/mL solution; dilute requisite dose in 100&#8239;mL infusion fluid; give over 30&#8211;60 minutes.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75849",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78289",
                "label": "MRSA",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1069",
                "label": "Tigecycline",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75849",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}